Kornelia Szebenyi

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategies.

Reframing cancer drug resistance: transporters, persister cells, senescence, and emerging therapeutic strategies.

Journal: Magyar onkologia
Published: April 17, 2026

Next-Gen Stroke Models: The Promise of Assembloids and Organ-on-a-Chip Systems.

Next-Gen Stroke Models: The Promise of Assembloids and Organ-on-a-Chip Systems.

Journal: Cells
Published: October 30, 2025

A human corticospinal organoid-slice connectoid model informs enhancer strategies for post-injury axon regrowth.

A human corticospinal organoid-slice connectoid model informs enhancer strategies for post-injury axon regrowth.

Journal: Cell reports
Published: September 13, 2025

Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementia.

Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementia.

Journal: Communications biology
Published: June 30, 2025

Origin and cell type specificity of mitochondrial DNA mutations in C9ORF72 ALS-FTLD human brain organoids.

Origin and cell type specificity of mitochondrial DNA mutations in C9ORF72 ALS-FTLD human brain organoids.

Journal: Science advances
Published: March 07, 2025

Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells.

Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: May 19, 2023

Inhibition of PHLDA3 expression in human superoxide dismutase 1-mutant amyotrophic lateral sclerosis astrocytes protects against neurotoxicity.

Inhibition of PHLDA3 expression in human superoxide dismutase 1-mutant amyotrophic lateral sclerosis astrocytes protects against neurotoxicity.

Journal: Brain communications
Published: May 13, 2023

Comparison of Different Clinical Chemotherapeutical Agents' Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells.

Comparison of Different Clinical Chemotherapeutical Agents' Toxicity and Cell Response on Mesenchymal Stem Cells and Cancer Cells.

Journal: Cells
Published: July 07, 2022

A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS.

A human proteogenomic-cellular framework identifies KIF5A as a modulator of astrocyte process integrity with relevance to ALS.

Journal: Communications biology
Published: June 25, 2022

P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

Journal: Cancers
Published: May 30, 2022

Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology.

Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology.

Journal: Nature neuroscience
Published: April 02, 2021

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.

Journal: Cancers
Published: April 01, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026